In the present work, we aimed to describe the frequency of these two EGFR polymorphisms among Brazilian breast cancer patients, and to evaluate their impact on breast cancer prognosis, exploring the effects of (CA)n polymorphism on EGFR transcript levels, and the associations of both polymorphisms with histopathological features and prognostic estimates. This evidence concerns the gene EGFR and breast cancer.